Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -4,7 +4,7 @@
4	4
5	5	= Company Overview =
6	6
7		-Pharmova is born out of a combination of ‘Pharma’ and ‘Nova’ (New) and Jubilant Pharmova Limited will continue to focus on offering products and services with, excellence in research and manufacturing, catering to the unmet health needs at an affordable price. {{footnote}}https://www.jubilantpharmova.com{{/footnote}}
	7	+Jubilant Pharmova Limited (NSE: JUBLPHARMA) Pharmova is born out of a combination of ‘Pharma’ and ‘Nova’ (New) and Jubilant Pharmova Limited will continue to focus on offering products and services with, excellence in research and manufacturing, catering to the unmet health needs at an affordable price. {{footnote}}https://www.jubilantpharmova.com{{/footnote}}
8	8
9	9
10	10	It is an integrated global pharmaceuticals company having three business segments Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs.
...	...	@@ -24,6 +24,7 @@
24	24
25	25	[[image:JUBLPHARMA1.png]]
26	26
	27	+{{putFootnotes/}}
27	27
28	28	= Business Segments =
29	29
...	...	@@ -56,7 +56,7 @@
56	56	One of the market leaders in the United States, based on market share of several key products
57	57
58	58
59		-== Contract Research and Development Services ==
	60	+== Contract R&D Services ==
60	60
61	61	Jubilant Biosys Ltd is a part of the Jubilant Pharmova family of companies with R&D centers in India and business offices in Asia and North America. With its global reach, Jubilant Biosys provides comprehensive drug discovery services and contract research services–from target discovery to candidate selection and with flexible business models (FFS, FTE and risk shared)–in partnership with leading worldwide healthcare companies. {{footnote}}https://www.jubilantbiosys.com/about-us/company-overview/{{/footnote}}
62	62
...	...	@@ -78,6 +78,7 @@
78	78
79	79	Jubilant Biosys collaborates with the world’s leading pharmaceutical, biotech companies, academic institutions and research foundations.
80	80
	82	+{{putFootnotes/}}
81	81
82	82	== Proprietary Novel Drugs ==
83	83